Bhatwadekar Ashay D, Shaw Lynn C, Grant Maria B
Dept of Pharmacology and Therapeutics, University of Florida, 1600 SW Archer Road Gainesville, FL 32610-0267, USA Tel.: + 1 352 392 9006
Expert Rev Endocrinol Metab. 2010 Jan;5(1):29-37. doi: 10.1586/eem.09.75.
Progressive obliteration of the retinal microvessels is a characteristic of diabetic retinopathy. The resultant retinal ischemia leads to sight-threatening neovascularization and macular edema. Bone marrow-derived endothelial progenitor cells play a critical role in vascular maintenance and repair and forms the basis of cellular therapy for revascularization of ischemic myocardium and ischemic limbs. Emerging studies show potential of these cells in revascularization of ischemic retina and this review summarizes this possibility. We also report current pharmacological options to correct diabetes-associated defects in endothelial progenitor cells for their therapeutic transfer.
视网膜微血管的进行性闭塞是糖尿病视网膜病变的一个特征。由此产生的视网膜缺血会导致威胁视力的新生血管形成和黄斑水肿。骨髓来源的内皮祖细胞在血管维持和修复中起关键作用,并构成了用于缺血心肌和缺血肢体血管重建的细胞治疗的基础。新兴研究显示了这些细胞在缺血视网膜血管重建中的潜力,本综述总结了这种可能性。我们还报告了目前用于纠正内皮祖细胞中与糖尿病相关缺陷以便进行治疗性移植的药理学选择。